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a main effect of Group (F 3,161.6 = 17.26, p < 0.001) and ROI (F 11,103.3 = 290.39, p < 0.001) and a significant interaction between Group and ROI (F 33,103 .3 = 1.80, p = 0.014). Posthoc two-sample t-tests for each region revealed significantly higher SERT BP ND in MC compared to FtM in the insula (p = 0.019), hippocampus (p = 0.032), amygdala (p < 0.001), caudate (p = 0.017), putamen (p = 0.005) and dorsal raphe nucleus (p = 0.009).
In the dorsal raphe nucleus, MC SERT BP ND was also higher compared to MtF (p = 0.037). When correcting for multiple comparisons using the Bonferroni procedure, differences remained significant only for the amygdala. No other group comparisons were significant although most regions in MtF had numerically higher BP ND values compared to FtM (see Table 1 ).
Testing the test-retest reliability in the subsample of 8 MC revealed high repeatability both in cortical (intra-class correlation coefficient [ICC] : insula = 0.84, anterior cingulate cortex = 0.95, middle cingulate cortex = 0.90) and subcortical regions (e.g., caudate = 0.90, putamen = 0.81, thalamus = 0.84). The ICC reflects the ratio of the between subjects variance to total variance, i.e., the stability of the measurement between time point 1 and time point 2 and was calculated from the results of a two-way ANOVA model with subjects treated as random effects and sessions treated as fixed effects. A paired t-test for each ROI in these subjects revealed no significant difference between the two measurements. Interestingly though, no significant differences were observed when comparing the significant SERT BP ND changes in FtM to the non-significant changes in MC. However, comparing the changes in MC with those in MtF revealed a significant difference in the insula (p = 0.02), anterior (p = 0.02), mid-(p = 0.02) and posterior cingulate (p = 0.003, uncorrected).
Testing Potential Confounders of Treatment Effects
Excluding the two FtM subjects receiving lynestrenol did not change the main findings but slightly increased p values for amygdala and median raphe nucleus and reduced p values, i.e., increased significances in hypothalamus, caudate, putamen and thalamus.
Including the type of anti-androgen treatment (cyproterone acetate vs. triptorelin acetate) in MtF as factor did not change the significance of main results. In no ROI was there a significant interaction between drug type and time point. Similarly, including finasteride intake as factor slightly increased p values for insula, anterior and midcingulate but decreased p values for caudate. In no ROI was there a significant interaction between drug type and time point.
When investigating a potential effect of an additional DSM-diagnosis on baseline SERT BP ND in transsexuals, neither the main effect nor the interaction with group was revealed to be significant. Table S1 ). However, in all other domains and in the global score of the WHOQOL-BREF there was no significant difference. Finally, Pearson product-moment correlations revealed no significant associations between clinical characteristics and regional SERT BP ND at each time point. 
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